| Quarterly Activities: Appendix 4C Cash Flow Report | 31/01/2025 | Quarterly Updates
| Download |
| Cleansing Notice | 19/12/2024 | Cleansing Notice
| Download |
| Notification regarding unquoted securities - BDX | 18/12/2024 | ASX Announcements
| Download |
| Notification of cessation of securities - BDX | 19/12/2024 | ASX Announcements
| Download |
| Change of Directors Interest Notices X 6 | 19/12/2024 | Notices
| Download |
| Notification regarding unquoted securities - BDX | 19/11/2024 | ASX Announcements
| Download |
| Application for quotation of securities - BDX | 19/12/2024 | ASX Announcements
| Download |
| Application for quotation of securities - BDX | 19/12/2024 | ASX Announcements
| Download |
| NATA Accreditation Clarification | 12/12/2024 | ASX Announcements
| Download |
| BCAL Diagnostics Receives NATA Accreditation | 12/12/2024 | ASX Announcements
| Download |
| Results of Meeting Revised | 27/11/2024 | Results of Meetings
| Download |
| BCAL Receives R&D Tax Offset $2.6 Million | 26/11/2024 | ASX Announcements
| Download |
| Results of Meeting | 22/11/2024 | Results of Meetings
| Download |
| Annual General Meeting Presentation | 22/11/2024 | Annual General Meeting
| Download |
| Australian Patent Accepted for BREASTEST Technology | 14/11/2024 | ASX Announcements
| Download |
| Change of Director's Interest Notice | 12/11/2024 | Notices
| Download |
| BCAL Commercial Update | 05/11/2024 | ASX Announcements
| Download |
| Quarterly Activities/Appendix 4C Cash Flow Report | 31/10/2024 | Quarterly Updates
| Download |
| Publication in Peer-Reviewed Journal | 29/10/2024 | ASX Announcements
| Download |
| Letter to Shareholders re AGM Notice | 22/10/2024 | Shareholder Updates
| Download |
| Notice of Annual General Meeting Proxy Form | 22/10/2024 | Annual General Meeting
| Download |
| Shareholder update | 16/10/2024 | Shareholder Updates
| Download |
| AGM Date and Director Nominations | 04/10/2024 | Annual General Meeting
| Download |
| Appendix 4G Corporate Governance Statement | 27/09/2024 | Other
| Download |
| BCAL Secures Commercial Licence Agreement with SBC | 23/09/2024 | ASX Announcements
| Download |
| Corporate Presentation | 19/09/2024 | Events and Presentations
| Download |
| Application for quotation of securities | 17/09/2024 | Cleansing Notice
| Download |
| Change in Directors Interest Notice | 17/09/2024 | Notices
| Download |
| Change of Director's Interest Notice | 05/09/2024 | Notices
| Download |
| Appendix 4E and Annual Report to Shareholders | 30/08/2024 | Shareholder Updates
| Download |
| BCAL Commences US Operations | 28/08/2024 | ASX Announcements
| Download |
| MST Access Report | 14/08/2024 | Publications
| Download |
| Cleansing Notice | 12/08/2024 | Cleansing Notice
| Download |
| Application for quotation of securities - BDX | 12/08/2024 | ASX Announcements
| Download |
| Quarterly Activities/Appendix 4C Cash Flow Report | 30/07/2024 | Quarterly Updates
| Download |
| Change in Directors Interest Notice | 23/07/2024 | Notices
| Download |
| Clreansing Notice | 23/07/2024 | Cleansing Notice
| Download |
| Application for quotation of securities | 23/07/2024 | ASX Announcements
| Download |
| Results of meeting | 15/07/2024 | Results of Meetings
| Download |
| BCAL to Present at Bioshares Biotech Summit - Presentation | 12/07/2024 | Events and Presentations
| Download |
| Change is substantial holding | 21/06/2024 | Trading Updates
| Download |
| Change of Director's Interest Notice | 17/06/2024 | Notices
| Download |
| Letter to Shareholders re General Meeting 15 July 2024 | 13/06/2024 | Shareholder Updates
| Download |
| Notice of General Meeting/Proxy Form | 13/06/2024 | Annual General Meeting
| Download |
| Cleansing Notice | 11/06/2024 | Cleansing Notice
| Download |
| Application for quotation of securities - BDX | 11/06/2024 | ASX Announcements, Trading Updates
| Download |
| Reinstatement to quotation | 03/06/2024 | ASX Announcements, Trading Updates
| Download |
| Proposed issues of securities | 03/06/2024 | ASX Announcements, Trading Updates
| Download |
| BCAL receive firm commitment to raise | 03/06/2024 | ASX Announcements
| Download |
| Suspension from quotation | 31/05/2024 | ASX Announcements, Trading Updates
| Download |
| Response to price query | 30/05/2024 | ASX Announcements
| Download |
| Trading Halt | 29/05/2024 | Trading Updates
| Download |
| Pause in Trading | 29/05/2024 | Trading Updates
| Download |
| Company presentation - investor insights | 02/05/2024 | Events and Presentations
| Download |
| Change in substantial holding | 01/05/2024 | Notices
| Download |
| 4C Quarterly Activities | 26/04/2024 | Quarterly Updates
| Download |
| Initial Directors Notice | 03/04/2024 | Notices
| Download |
| Ceasing to be a substantial shareholder | 03/04/2024 | Shareholder Updates
| Download |
| Trademark announcement | 02/04/2024 | ASX Announcements
| Download |
| Change in substantial holding | 27/03/2024 | Trading Updates
| Download |
| Corporate Presentation | 06/03/2024 | Events and Presentations
| Download |
| Appointment of Strategic CEO to Lead Commercial Launch | 06/03/2024 | ASX Announcements
| Download |
| Final Directors Notice | 04/03/2024 | Notices
| Download |
| Initial Directors Notice | 04/03/2024 | Notices
| Download |
| BCAL to host Investor webcast | 01/03/2024 | Events and Presentations
| Download |
| Cleansing notice | 28/02/2024 | Cleansing Notice
| Download |
| BCAL Strengthens Board with Appointment of Commercial NED | 29/02/2024 | ASX Announcements
| Download |
| Quarterly Activities/Appendix 4C Cash Flow Report | 30/01/2024 | Quarterly Updates
| Download |
| Collaboration with KIMS & Indo-American Hospitals Hyderabad | 29/11/2023 | ASX Announcements
| Download |
| BCAL Files Further Foundational Patent Application | 06/11/2023 | ASX Announcements
| Download |
| Quarterly Activities/Appendix 4C Cash Flow Report | 31/10/2023 | Quarterly Updates
| Download |
| BCAL Locks Down Crucial Breast Cancer Signature | 11/09/2023 | ASX Announcements
| Download |
| Shane Ryan Appointed Chief Operating Officer | 04/09/2023 | ASX Announcements
| Download |
| Cleansing Notice | 01/09/2023 | Cleansing Notice
| Download |
| Application for quotation of securities - BDX | 01/09/2023 | ASX Announcements
| Download |
| Preliminary Final Report | 30/08/2023 | Other
| Download |
| Share Purchase Plan Offer Booklet | 30/08/2023 | ASX Announcements, Shareholder Updates
| Download |
| Proposed issue of securities - BDX | 29/08/2023 | ASX Announcements
| Download |
| $2.4m Capital Raise to Further BREASTEST Commercialisation | 28/08/2023 | ASX Announcements
| Download |
| Investor Presentation | 24/08/2023 | Events and Presentations
| Download |
| ASX Announcement - Trading Halt | 04/08/2023 | ASX Announcements, Trading Updates
| Download |
| BCAL Investor Education Update & Webinar | 08/08/2023 | Events and Presentations
| Download |
| Breakthrough Results a Major Step Towards Commercialisation | 02/08/2023 | ASX Announcements, Scientific Evidence
| Download |
| ASX Annoucement | 28/07/2023 | ASX Announcements
| Download |
| ASX Annoucement | 28/07/2023 | ASX Announcements
| Download |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27/07/2023 | Quarterly Updates
| Download |
| Shareholder Newsletter | 20/07/2023 | Shareholder Updates
| Download |
| ASX Annoucement | 30/06/2023 | ASX Announcements
| Download |
| ASX Annoucements | 30/06/2023 | ASX Announcements
| Download |
| BCAL appoints David Darling as an advisor | 16/05/2023 | ASX Announcements
| Download |
| ASX Annoucement | 11/05/2023 | ASX Announcements
| Download |
| ASX Annoucement | 03/05/2023 | ASX Announcements
| Download |
| BCAL Opens Development & Clinical Service Laboratory | 03/05/2023 | ASX Announcements
| Download |
| ASX Annoucement | 24/04/2023 | ASX Announcements
| Download |
| ASX Annoucement | 16/01/2023 | ASX Announcements
| Download |
| Recent Analysis Significantly Improves Commercial Prospects | 07/02/2022 | ASX Announcements
| Download |
| Establishment of Development & Clinical Services Laboratory | 05/10/2022 | ASX Announcements
| Download |
| BCAL Enters US Product Development Agreement with Precion | 28/06/2022 | ASX Announcements
| Download |
| Shareholder Newsletter | 15/11/2022 | Shareholder Updates
| Download |
| Dr John Hurrell Appointed Chief Executive Officer | 11/01/2022 | ASX Announcements
| Download |
| Notice of Annual General Meeting and Explanatory Statement | 21/10/2021 | Annual General Meeting, Notices
| Download |
| Australian Clinical Studies Launched | 03/09/2021 | ASX Announcements
| Download |
| Market Update | 17/08/2021 | ASX Announcements
| Download |
| Becoming a substantial holder | 22/07/2021 | Other, Trading Updates
| Download |
| BCAL Diagnostics to list after raising $10m in IPO | 21/07/2021 | ASX Announcements
| Download |
